Trulance Immediate release 3 mg/1
Plecanatide · TABLET · Salix Pharmaceuticals Inc.
Trulance Immediate release is a tablet containing plecanatide at 3 mg/1, taken oral. Manufactured by Salix Pharmaceuticals Inc..
Key Facts
- Brand Name
- Trulance Immediate release
- Generic Name
- Plecanatide
- NDC Code (Product)
65649-003- Manufacturer
- Salix Pharmaceuticals Inc.
- Strength
- 3 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA208745
- Drug Class
- Guanylate Cyclase-C Agonist [EPC]
- Marketing Start
- 02/21/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Trulance Immediate release used for?
Trulance Immediate release contains Plecanatide. It is a tablet taken oral. Consult your doctor for specific uses.
Is Trulance Immediate release a controlled substance?
Trulance Immediate release is not classified as a controlled substance by the DEA.
What is the generic name for Trulance Immediate release?
The generic name for Trulance Immediate release is Plecanatide. There are no other listed brand versions of Plecanatide.
What is the NDC code for Trulance Immediate release 3 mg/1?
The NDC (National Drug Code) for Trulance Immediate release 3 mg/1 is 65649-003, listed by Salix Pharmaceuticals Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)